Between November 1985 and January 1988. a t o t a l o f 18 c h i l d r e n born t o HIV-infected mothers were i d e n t i f i e d .
Seventeen o f these pregnant women were IV drug abusers, one was a sexual partner o f a high r i s k male and four o f them were also p r o s t i t u t e s .
A l l 18 women were symptom-free during pregnancy and only two developed HIV i n f e c t i o n .
Nine c h i l d r e n were delivered by caesarean section and nine vaginally. A11 newborns were HIV-seropositive by ELISA and Western-blot a t b i r t h . Seven c h i l d r e n had l o s t antibody a t a median time o f nine months, were negative f o r HIV antigen and remained asymptomatic a t a mean age o f 20 months.
Six c h i l d r e n were HIV-antibody p o s i t i v e a t a median age o f 7.3 months b u t were HIV-antigen negative and were c l i n i c a l l y well. Four c h i l d r e n developed HIV infection; two o f them had serum HIV-antigen. Another c h i l d remained seropositive a t 24 months and a f o u r t h p a t i e n t had persistant HIV-antibody together w i t h a c e l l u l a r and humoral inmunodeficiency and c l i n i c a l stage o f P-2-A.
Of these four HIV-infected children, only two were delivered by caesarean section and none o f them were breastfed.
One c h i l d d i d not cone t o follow-up control. Prevalence o f v e r t i c a l transmission o f HIV from i n f e c t e d mothers t o c h i l d r e n i n our seroepidemiological study was 23.5%. however t h i s percentage may become higher i f closer contact o f a l l high r i s k pregnant women i s achieved.
I n our small series, neither the mode o f delivery. nor breast-feeding, were r e l a t e d t o v e r t i c a l l y transmitted HIV infection.
KAWASAKI SYNDROHE IN BERNE, SWITZERLAND, 1977 -1986 3010 Berne, Swi tz&land; ' The purposes o f t h i s retrospective study o f the 26 patients (17 male (67%), 9 female (35%); mean age S O = 2.8 2 years) treated f o r Kawasaki syndrome a t our centre since 1977 were t o describe t h e i r c l i n i c a l and laboratory presentation, and t o evaluate high-risk factors f o r the developnent o f coronary a r t e r i a l c~l p l i c a t i o n s and e f f e c t s o f d i f f e r e n t therapies i n preventing the coronary involvement.
The diagnostic c r i t i e r i a were met by 100% f o r fever and rash, by 96% f o r d i g i t a l desquamation, by 92% f o r b i l a t e r a l conjunctival i n j e c t i o n and mucous membrane changes, by 81% f o r c e r v i c a l lymphadenopathy. and by 54% f o r peripheral edema/erythema. Treatment i n c l uned aspirin, i n the beginning also a n t i b i o t i c s , and since 1986 highdose intravenous inmune globulins (IVIG).
Regular routine electrocardiogram and echocardiogram c o n t r o l s recorded 9 cardiovascular complications: 6x c a r d i t i s (23%) and 3x coronary a r t e r y aneurysm (12%). The 3 p a t i e n t s w i t h coronary aneurysm were a l l males. and compared t o the others both younger (22 vs. 33 mths) and f e b r i l e over a longer period o f time (22 vs 12 dys); elevated acute-phase reactants such as ESR, leukocyte and p l a t e l e t counts were s i m i l a r i n both groups and d i d n o t a f f e c t prognosis.
Since the therapeutic use o f IVIG no more cardiac c m p l i c a t i o n s were detected. A l l patients are c l i n i c a l l y cured. The findings o f c a r d i t i s i n 6 and o f coronary aneurysm i n 2 p a t i e n t s completely resolved; one p a t i e n t w i t h regressive coronary aneurysm shows myopathic cardiolnegaly a f t e r 2 yrs. Twenty e i g h t i n f a n t s and c h i l d r e n (3-63 months) w i t h Kawasaki disease received intravenous innunoglobulins (IVIG) i n a m u l t i c e n t r i c study: Veinoglobulin (Merieux, France) i n 24 cases o r Sandoglobulin (Sandoz, Switzerland) i n 4 cases.. The t o t a l amount administered was i n the range 1-2.5g/Kg and varied from 1 to 5 d a i l y infusions.
I n 16 cases the patients received 0.4 mq/Kg/day during 5 consecutive days. A l l o f them were given o r a l l y a c e t y l s a l i c y l i c a c i d 30 mg/Kg/day during a 2 month period.
A dramatic improvement i n the p a t i e n t s ' general condition was observed, w i t h resolution o f fever w i t h i n 48 hours. Hyperfibrinemia and hyperleucocytosis returned t o normal i n one week and incresed p l a t e l e t s w i t h i n 2-3 weeks.
An important feature was t h a t follow-up echocardiograms over more than one year have demonstrated no coronary a r t e r y abnormalities.
Five out o f 6 c h i l d r e n studied imnunologically during the acute phase presented w i t h a deficiency o f c i r c u l a t i n g CD8 T c e l l s w i t h an increased CO4/CD8 r a t i o .
High doses o f IVIG were followed w i t h an increase o f serum IgM, CD8 T c e l l s and a normalisation o f CD4/CD8 r a t i o .
High dosage IVIG represents the treatment o f choice o f Kawasaki syndrome; t h i s a c t i v i t y focuses the deficiency o f the imnunoregulatory function i n Kawasaki syndrome. 
I n Novenber 1984 Furusho e t a1 published t h e i r r e s u l t s suggesting t h a t I V 1GG prevents coronary a r t e r y aneurysm formation i n Kawasaki Disease.
These r e s u l t s were confirmed i n an open c o n t r o l l e d multicenter study by Newburger e t a1 i n 1986. I n Finland new cases o f KO have been registered since 1981.
To determine the value o f IV IGG i n Finnish KO p a t i e n t s the records o f patients registered i n 1985-87 were reviewed.
Seventy-one patients were registered. Data on both treatment and findings o f coronary echocardiography were available on 63 patients.
Coronary aneurysms were detected i n 3/44 patients treated w i t h a s p i r i n + IV IGG and 3/19 patients treated w i t h a s p i r i n only. Two o f the untreated c h i l d r e n w i t h aneurysms f u l f i l l e d only 4 o f the 6 c r i t e r i a o f KD. These data are i n accord w i t h the suggested b e n e f i t o f I V IGG i n preventing aneurysm formation i n KO. When t r e a t i n g Kawasaki p a t i e n t s w i t h I V IGG we are facing the following problems:
-patients w i t h diseases other than KO w i l l be treated; -KD p a t i e n t s not f u l f i l l i n g the c r i t e r i a w i l l not be treated o r t h e i r treatment w i l l be delayed;
-an occasional p a t i e n t w i t h IgA deficiency w i l l be treated; -the f i n a l didgnosis may be obscured as the treatment modifies the c l i n i c a l p i c t u r e and i n v a l i d a t e s the r e s u l t s o f b a c t e r i a l and v i r a l serology.
C-REACTIVE PROTEIN IN KAWASAKI OISEASE
J. Boulloche * E. M a l l e t F. Pollet**et a1 .*** 9 t o 1 1 aborativ; study ~~~~' E V R E U X (**I, LISEU~ (***) ROUEN (*I Children's Hospitals -France.
C-reactive p r o t e i n (CRP) l e v e l s were investigated i n 8 cases o f Kawasaki disease (KO) a l l treated w i t h high doses o f intravenous gamaglobulin (400 ag/kg) f o r 3 days). Medium i n i t i a l value o f CRP was 190 mg/100 ml (range 129-284).
The delay between the onset o f the disease and treatment was 12.5 days (5-24).
I n a l l cases CRP normalized dramatically w i t h a mean delay o f 3.5 days (range 0 -7 9 s ) a f t e r the end o f treatment.
This b i o l o g i c parameter normalized before other inflarnnatory tests. such as erythrocyte sedimentation rate, p l a t e l e t count, fibrinogen and IgE.
Both apyrexia occured and skin lesions evolution stopped.
One p a t i e n t w i t h coronary a r t e r y involvement was treated a f t e r a delay o f 24 days when cardiac lesions were already present.
CRP value was normal 24 hours a f t e r the onset o f treatment and coronary lesions stabilized.
Monitoring o f CRP appears t o be an accurate index i n c l i n i c a l practice. Furthermore dramatic normalization o f CRP should be considered o f i n t e r e s t i n imunoglobulin e f f i c a c y and i n i n d i r e c t approach O f KO pathophysiology. The f i r s t LGB p a t i e n t s i n Hungary were diagnosed i n 1984, and a few more i n 1985.
AN OUTBREAK OF BELLS'S PALSY
But only following the introduction o f serological t e s t s ( i n d i r e c t imunofluorescence) i n 1986 that i n t e r e s t i n the i l l n e s s was aroused. During the l a s t two years m r e than 2000 sera and CSF samples from 1400 patients have been tested f o r B o r r e l i a burgdorferi antibody. 92 o f 1400 patients suffered from peripherial f a c i a l palsy. 35/92 were found to be s e r o l o g i c a l l y positive.
19 o f them were seen during the sumer and f a l l o f 1987. I n t h i s year twice as many D e l l ' s palsy patients were seen i n our hospitals than i n previous years.
Of the 35 c l i n i c a l l y and s e r o l o g i c a l l y proven cases: 14 showed ECM; 10 had other neurological manifestations (Bannwarth's syndrome); 1 had frank a r t h r i t i s ; 1 had c a r d i t i s . 18/33 seropositive Be1 1 ' s palsy patients were children. The c l i n i c a l picture. epidemiology, serology and CSF findings o f these cases w i l l be discussed.
Almost a l l o f the seropositive patients became free o f symptoms.
The longest period o f recovery was 100 days.
Residual symptom was found only i n those patients t h a t remained seronegative during a minimum o f 45 days serological follow-up period o r d i d not receive adequate parenteral a n t i b i o t i c therapy.
H a l f o f the seropositive patients had lymphocytic meningitis. Only one seronegative case had pleocytosis i n the CSF.
